It has been reported that during the progression of prostate cancer (PCa), aberrantly expressed HOXA2, HOXA9, and HOXA10 facilitate the infiltration of dendritic cells, macrophages, and mastocytes [80]. The gene discussed is HOXA10; the disease is prostate cancer.